Form 4: Korro Bio Director Receives Stock Option Grant

Director Rachel Meyers was granted 14,677 stock options in Korro Bio, Inc. as part of a standard equity compensation arrangement.

Summary

• Director Rachel Meyers received a grant of 14,677 stock options.
• The options have an exercise price of $10.59 per share.
• The grant date for the transaction was June 10, 2026.
• The options are set to expire on June 9, 2036.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting routine director compensation rather than a signal of operational performance.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• The grant results in potential future dilution for existing shareholders upon exercise.

Risks

• Market volatility affecting the value of the underlying common stock relative to the $10.59 exercise price.

Future Outlook

The options vest in full on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting of stockholders, contingent upon continued service.

Management Comments

• No specific management commentary provided in this regulatory filing.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practices in the biotechnology sector to ensure board retention and alignment with company performance.

Comparison to Industry Standards

• The vesting schedule (one year or next annual meeting) is consistent with standard director compensation packages for mid-cap biotech firms.
• The use of stock options as a primary incentive tool remains a common practice for clinical-stage companies to preserve cash.

Stakeholder Impact

• Minor potential dilution for shareholders upon future exercise of options.

Next Steps

• Vesting of options on the earlier of June 10, 2027, or the next annual meeting of stockholders.

Key Dates

Keywords

Korro Bio, KRRO, Form 4, Insider Trading, Stock Options, Director Compensation